Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Plos One|June 19, 2015
Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer CellsMarkus Hecht, Sonja Erber, Thomas Harrer, et al.
Journal of Clinical Medicine|February 15, 2022
Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland CancerSarina K Mueller, Marlen Haderlein, Sebastian Lettmaier, et al.
International Journal of Clinical and Experimental Pathology|February 18, 2016
Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcomePia B Erben, Kathrin Brunner, Markus Hecht, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 18, 2020
Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working groupLukas Käsmann, Annemarie Schröder, Benjamin Frey, et al.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2016
PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosisMarkus Hecht, Maike Büttner-Herold, Katharina Erlenbach-Wünsch, et al.
BMC Palliative Care|April 9, 2022
Advance directives in patients with head and neck cancer - status quo and factors influencing their creationMoritz Allner, Magdalena Gostian, Matthias Balk, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 15, 2025
Intra-adaptational changes in online adaptive radiotherapy: from the ideal to the real doseHanna Malygina, Hendrik Auerbach, Marc Ries, et al.
Oral Oncology|December 2, 2019
Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1)Sabine Semrau, Daniela Schmidt, Markus Hecht, et al.
Frontiers in Oncology|August 9, 2021
Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma: Case Report and Assessment of Histological ResponseManuel Olmos, Jacek Glajzer, Tjark-Ole Büntemeyer, et al.
HNO|March 16, 2022
[Highlights from the 2021 ASCO and ESMO annual meetings on radiotherapy of head and neck cancer]Markus Hecht, Jens von der Grün, Sabine Semrau, et al.
Pageof 13